IP Verse

Compositions And Methods Of Immunizing Against C. Difficile - EP3007724

The patent EP3007724 was granted to Sanofi Pasteur on Jul 5, 2023. The application was originally filed on Jun 13, 2014 under application number EP14737429A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3007724

SANOFI PASTEUR
Application Number
EP14737429A
Filing Date
Jun 13, 2014
Status
Granted And Under Opposition
Jun 2, 2023
Grant Date
Jul 5, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERApr 5, 2024PFIZERADMISSIBLE

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2005058353
OPPOSITIONWO2009035707

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Stavros Sougioultzis ET AL, "Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea", Gastroenterology, AMSTERDAM, NL, (20050301), vol. 128, no. 3, doi:10.1053/j.gastro.2004.11.004, ISSN 0016-5085, pages 764 - 770, XP055387434
OPPOSITION- Anonymous, "Final Programme European Congress of Clinical Microbiology and Infectious Diseases", ECCMID, Barcelona ,Spain, (20140501), pages 1 - 368, XP093182669-
OPPOSITION- Anonymous, "Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection", Clinical Trials : (NCT00772343), (20120628), pages 1 - 6, Clinical Trials : (NCT00772343), URL: https://clinicaltrials.gov/study/NCT00772343?tab=history&a=17&b=17, (20240705), XP093182697-
OPPOSITION- Anonymous, "Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults", Clinical Trials (NCT01230957), (20120801), pages 1 - 9, Clinical Trials (NCT01230957), URL: https://clinicaltrials.gov/study/NCT01230957?tab=history&a=5, (20240705), XP093182700-
OPPOSITION- De Bruyn Guy, Foglia Ginamarie, Saleh Jamshid, Workman David, Pollak Richard, Gesser Richard, "A Phase II study of the safety and immunogenicity of different formulations of a candidate clostridium difficile toxoid vaccine :Dose and formulation selection for fase III", 24th Annual Meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), (20140501), pages 1 - 1, XP093182665-
OPPOSITION- De Bruyn Guy, Foglia Ginamarie, Saleh Jamshid, Workman David, Pollak Richard, Gesser Richard, "A Phase II study of the safety and immunogenicity of different vaccination schedules of a candidate clostridium difficile toxoid vaccine : vaccination schedule selection for phase III", 24th Annual Meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, (20240501), pages 1 - 1, XP093182662-
OPPOSITION- Fu Si-Wu, Zhou Dian-Yuan, "Purification of Clostridium difficile toxin A", Chinese Journal of Biochemical Pharmaceutics, CN , (20040330), vol. 25, no. 2, ISSN 1005-1678, pages 86 - 88, XP093182685-
OPPOSITION- Ginamarie Foglia, Siddhi Shah, Christine Luxemburger, Patricia J. Freda Pietrobon, "Clostridium difficile: Development of a novel candidate vaccine", Vaccine, (20120601), vol. 30, no. 29, doi:10.1016/j.vaccine.2012.01.056, ISSN 0264-410X, pages 4307 - 4309, XP055060922
OPPOSITION- Greenberg R N, Marbury T C, Foglia G, Warny M., "Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine.", Vaccine, United Kingdom , (20120316), vol. 30, no. 13, doi:10.1016/j.vaccine.2012.01.065, ISSN 1873-2518, pages 2245 - 2249, XP002730905
OPPOSITION- de Bruyn Guy; Gordon David L; Steiner Theodore; Tambyah Paul; Cosgrove Catherine; Martens Mark; Bassily Ehab; Chan Eng-Soon; Patel Dhaval; Chen Josh; Torre-Cisneros Julian; Fernando De Magalhães Francesconi Carlos; Gesser Richard; Jeanfreau Robert; Launay Odile; Laot Thelma; Morfin-Otero Rayo; Oviedo-Orta Ernesto; Park Yoon Soo; Piazza Franco M; Rehm Christine; Rivas Enrique; Self Steve; Gurunathan Sanjay, "Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial", The Lancet Infectious Diseases, AMSTERDAM, NL , (20200915), vol. 21, no. 2, doi:10.1016/S1473-3099(20)30331-5, ISSN 1473-3099, pages 252 - 262, XP086473771
OPPOSITION- Stavros Sougioultzis, Lorraine Kyne, Denise Drudy, Sarah Keates, Seema Maroo, Charalabos Pothoulakis, Paul J. Giannasca, Cynthia K. Lee, Michel Warny, Thomas P. Monath, Ciarán P. Kelly, "Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea", Gastroenterology, US , (20050301), vol. 128, no. 3, doi:10.1053/j.gastro.2004.11.004, ISSN 0016-5085, pages 764 - 770, XP055387434
OPPOSITION- Karen L. Kotloff, Steven S. Wasserman, Genevieve A. Losonsky, William Thomas, Jr, Richard Nichols, Robert Edelman, Margaret Bridwell,Thomas P. Monath, "Safety and immunogenicity of increasing doses of a clostridium difficile toxoid administrated to healthy adults", Infection and immunity, US , (20010201), vol. 69, no. 2, doi:10.1128/IAI.69.2.988-995.2001, ISSN 0019-9567, pages 988 - 995, XP002986519
OPPOSITION- Aboudola Samer; Kotloff Karen L; Kyne Lorraine; Warny Michel; Kelly Eoin C; Sougioultzis Stavros; Giannasca Paul J; Monath Thomas P; Kelly Ciaran P, "Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A.", Infection and immunity, US , (20030301), vol. 71, no. 3, doi:10.1128/IAI.71.3.1608-1610.2003, ISSN 0019-9567, pages 1608 - 1610, XP009108959
OPPOSITION- FU Si-wu,MAO Min-yan,SU Lu,MI You-jun, "Purification and Biological Characteristics of Toxin B of Clostridium difficile", Chinese Journal of Biologicals, (20111020), vol. 24, no. 10, doi:10.13200/j.cjb.2011.10.102.fusw.009, pages 1217 - 1219+1223, XP093182690
OPPOSITION- Leuzzi R; Adamo R; Scarselli M, "Vaccines against Clostridium difficile", Human vaccines & immunotherapeutics, US , (20140601), vol. 10, no. 6, doi:10.4161/hv.28428, ISSN 2164-5515, pages 1466 - 1477, XP009180634

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents